Adrenergic Receptors: ɑ Subtype
Spare Receptors
Factors Affecting Protein-Drug Binding: Protein-Related Factors
Insulin: The Receptor and Signaling Pathways
Receptor-mediated Endocytosis
Adrenergic Receptors: β Subtype
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 8, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Zhuoying Liu1, Ting Xiao1, Xiaoyu Peng1
1Department of Metabolism and Endocrinology, Metabolic Syndrome Research Center of Central South University, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
APPL proteins are important signaling adaptors that help regulate metabolism. They interact with receptors for hormones like adiponectin and insulin. These interactions influence processes like lipid oxidation and glucose uptake. APPL1 and APPL2 are two major forms of these proteins. They differ in where they are found and how they function. APPL1 helps with adiponectin and insulin signaling. APPL2 plays a key role in endosomal trafficking. Understanding how APPLs work could lead to new treatments for metabolic and neurodegenerative diseases. This review highlights the growing evidence for their roles in cell signaling and metabolism.
Area of Science:
Background:
Obesity and diabetes remain widespread health challenges. Scientists have explored how cells regulate metabolism and energy balance. Adiponectin and insulin are key hormones involved in these processes. They act through receptors and signaling proteins in the cell. However, the exact mechanisms by which these signals are transmitted remain unclear. APPL proteins have emerged as potential players in this signaling network. Prior research has shown their involvement in lipid and glucose metabolism. But the full extent of their roles is still being uncovered. This gap motivated researchers to examine APPLs in more detail.
Purpose Of The Study:
This review aims to clarify the roles of APPL proteins in cellular signaling. The focus is on APPL1 and APPL2, two major isoforms. The study explores how these proteins interact with adiponectin and insulin receptors. The goal is to understand how APPLs influence metabolic processes. Researchers also investigate their impact on endosomal trafficking and other pathways. This work builds on existing knowledge of APPLs as signaling adaptors. The motivation is to identify potential therapeutic applications. Understanding these mechanisms may aid in treating metabolic and neurodegenerative disorders.
Main Methods:
The researchers conducted a comprehensive literature review. They analyzed published studies on APPL proteins and their interactions. Data were collected on APPL1 and APPL2 functions in signaling pathways. The review approach included examining studies on adiponectin and insulin signaling. Researchers also looked at how APPLs affect endosomal trafficking. They synthesized findings from multiple experimental models. The study compared results from in vitro and in vivo experiments. The synthesis focused on how APPLs contribute to metabolic regulation.
Main Results:
APPL1 was found to interact with adiponectin receptors. This interaction enhances lipid oxidation and glucose uptake. APPLs also play a role in insulin signaling pathways. They help mediate insulin's effects on cell metabolism. APPL1 and APPL2 differ in their tissue distribution and functions. APPL2 appears to regulate endosomal trafficking more prominently. The review highlights their roles in chromatin remodeling and apoptosis. These findings suggest APPLs are key regulators of metabolic homeostasis.
Conclusions:
The authors propose that APPLs are more than just receptor-binding proteins. They suggest these proteins have broader roles in cell signaling. APPL1 and APPL2 appear to influence multiple pathways. The review supports the idea that APPLs contribute to metabolic regulation. The findings may lead to new therapeutic strategies. The authors note the need for further research on APPL isoforms. They suggest that targeting APPLs could help treat metabolic diseases. The synthesis emphasizes the importance of understanding APPL signaling in health and disease.
APPL1 interacts with adiponectin receptors to enhance lipid oxidation and glucose uptake.
APPL1 and APPL2 both mediate insulin signaling but have distinct tissue distributions and functions.
APPL2 appears to play a significant role in regulating endosomal trafficking, which affects signaling efficiency.
APPLs contribute to chromatin remodeling, which influences gene expression and cell function.
APPL1 enhances glucose uptake by mediating adiponectin and insulin signaling pathways.
The authors suggest APPLs may lead to treatments for obesity, diabetes, and neurodegenerative diseases.